Multifaceted biomedical applications of bismuth oxide-doped bioactive glass: Synthesis challenges, characterization and potential clinical implications

Herewith, the present work reports a facile synthesis method of Bi2O3 doped 70 SiO2.30CaO binary bioactive glass system termed as modified Bi-BG (acronymed as mBi-BG) that indicates successful incorporation of Bi3+ into the silicate glassy network, on prior complex formation of the precursor bismuth nitrate salt with acetyl acetone to address the rapid decomposition rate of precursor bismuth nitrate. The binary bioactive glass composition as above mentioned (70 SiO2.30CaO) is named as BG/Control. The synthesis methodology addresses inherent challenges encountered in traditional sol-gel derived bismuth oxide incorporated bioactive glass (Bi-BG) synthesis wherein yellow coloured bismuth oxide gets separated from the glassy network as confirmed by XRD phase analysis. Next, mBi-BG (modified Bi-BG) was synthesized via modifying the sol gel method by introducing a chelating agent acetyl acetone to stabilize the precursor Bi (NO3)3 salt, and was characterized using XRD, FTIR, FESEM-EDX. TG-DSC and BET isotherm. In vitro bioactivity studies illustrate the formation of hydroxyapatite crystals on mBi-BG surface indicating its potential for bone repair and regeneration. Additionally, mBi-BG exhibits significant effect against Staphylococcus aureus (gram-positive) bacterial strain, highlighting its utility in preventing bacterial infections at surgical sites. Radiographic imaging of mBi-BG reveals excellent radiopacity comparable to human bone, rendering it suitable for image-guided surgeries and fluoroscopic procedures. In summary, mBi-BG emerges as a versatile biomaterial with enhanced bioactivity, antibacterial efficacy and radiopacity, thereby offering novel avenues in medical treatment modalities and patient care. © 2024 Elsevier Ltd and Techna Group S.r.l.